All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Caspase-Dependent Apoptosis | NCIT_C42785 | [Any apoptotic process that involves pathways that activate intracellular proteolytic caspases.] |
| CARD11 wt Allele | NCIT_C60669 | [Human CARD11wild-type allele is located within 7p22 and is 138 kb in length. This allele, which encodes caspase recruitment domain-containing protein 11, plays a role in apoptosis regulation and signal transduction.] |
| Sialyl Lewis-Keyhole Limpet Hemocyanin Conjugate Vaccine | NCIT_C69000 | [A vaccine consisting of the oligosaccharide antigen sialyl Lewis (CA19-9) conjugated to the nonspecific immunomodulator keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. Upon administration, sialyl Lewis-keyhole limpet hemocyanin conjugate vaccine may induce production of IgG and IgM antibodies as well as trigger an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells expressing the sialyl Lewis antigen. Sialyl Lewis is a blood group antigen and a tumor-associated antigen associated with epithelial cancers such as breast cancer and various digestive cancers. Sialyl Lewis serves as a ligand for the cytokine-inducible cell adhesion molecule (CAM) E-selectin, an endothelial cell-specific type I transmembrane surface protein, thus facilitating hematogenous metastasis by mediating the adhesion of circulating cancer cells to vascular endothelium.] |
| Immunoconjugate | NCIT_C1512 | [An agent that consists of an immune substance, such as a monoclonal antibody, antigen or an immunoglobulin, and covalently bound to other molecule(s), usually either a toxin, a radioisotope, or a cytotoxic agent. Immunoconjugates allow for specific delivery of certain substances to specific cells or tissues for diagnostic or therapeutic purposes.] |
| Concentrated Oral Dosage Form | NCIT_C69001 | [A concentrate that usually requires dilution prior to oral administration.] |
| Concentrated Dosage Form | NCIT_C60891 | [A solution or suspension composed of active and/or inert ingredient(s) with increased strength in a reduced volume, which is usually diluted prior to administration.] |
| Oral Dosage Form | NCIT_C42744 | [A substance intended for administration through the mouth.] |
| Compressed Sugar Coated Caplet Dosage Form | NCIT_C69002 | [A tablet that has been compacted into capsule shape and covered in sugar.] |
| Oral Tablet Dosage Form | NCIT_C43243 | [A tablet intended for oral administration.] |
| Tablet 24 Hour Sustained Release Dosage Form | NCIT_C69003 | [A tablet designed to release active and/or inert ingredient(s) slowly so as to achieve a constant circulating concentration of the ingredient over a 24 hour time interval.] |
| Sustained Release Tablet Dosage Form | NCIT_C78751 | [A tablet designed to release active and/or inert ingredient(s) slowly so as to achieve a constant circulating concentration of the ingredient over a period of time.] |
| Tablet 12 Hour Sustained Release Dosage Form | NCIT_C69004 | [A tablet designed to release active and/or inert ingredient(s) slowly so as to achieve a constant circulating concentration of the ingredient over a 12 hour time interval.] |
| Pladienolide Derivative E7107 | NCIT_C69005 | [A synthetic urethane derivative of pladienolide D with potential antineoplastic activity. Pladienolide derivative E7107 is generated from the 12-membered macrolide pladienolide D, one of several macrolides derived from the bacterium Streptomyces platensis Mer-11107. This agent appears to bind to the 130-kDa subunit 3 (spliceosome-associated protein 130; SAP130) of the splicing factor 3b (SF3b), resulting in inhibition of pre-messenger RNA splicing and the arrest of cell-cycle progression. The splicing factor SF3b is a multiprotein complex integral to the accurate excision of introns from pre-messenger RNA; the subunit SAP130 associates with U2 snRNP and is recruited to prespliceosomal complexes.] |
| Antineoplastic Antibiotic | NCIT_C259 | [An antibiotic, or its derivative, that can kill or inhibit the growth of tumor cells. Antineoplastic antibiotics can interfere with the normal function of cellular nucleic acids and proteins.] |
| Macrolide | NCIT_C67445 | [A term used to describe a chemical structure of a compound containing a large lactone ring, usually with a 14 or 16-membered ring structure. The prototypical compounds within the macrolide class are the erythromycin-based antibiotics; however, many compounds with this chemical structure are being developed for other diseases.] |
| Tablet Particle Crystal Dosage Form | NCIT_C69006 | [A tablet composed of small fragments of singular, repeating units of that are systematically arranged over an evenly spaced lattice.] |
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 | NCIT_C60673 | [Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (824 aa, ~92kDa) is encoded by the MALT1 gene. This protein may play a role in NF-kappa-B activation.] |
| Signaling Protein | NCIT_C18515 | [Proteins or peptides that participate in signal transduction processes in the cell.] |
| MALT1 Gene | NCIT_C60671 | [This gene plays a role in signal transduction and in the pathology of mucosa-associated lymphoid tissue lymphomas.] |
| Chromogranin A Positive Neoplastic Cells Present | NCIT_C60674 | [An immunophenotypic test result indicating positive staining of neoplastic cells for chromogranin A.] |